Given the critical role of the JAK/STAT pathway in the tumor microenvironment, these findings underscore the need for further investigations to elucidate the molecular mechanisms involved and evaluate the potential of these alterations as therapeutic targets or prognostic biomarkers in this aggressive subtype of breast cancer. This evidence concerns the gene SOAT1 and neoplasm.